maltofer fol
vifor france, francúzsko - Železo v kombinácii s kyselinou listovou - 12 - antianaemica
ferro-folgamma
wÖrwag pharma gmbh & co.kg, nemecko - Železo, vitamín b12 a kyselina listová - 12 - antianaemica
gelofusine
b.braun melsungen ag, nemecko - Želatínové látky - 76 - infundibilia
gelaspan 4%
b.braun melsungen ag, nemecko - Želatínové látky - 76 - infundibilia
ferinject
vifor france, francúzsko - parenterálne lieky s trojmocným železom - 12 - antianaemica
katéter balónikový pta zelos
optimed medizinische instrumente gmbh. ferdinand-porsche-strasse 11 d-76275 ettlingen nemecko -
velphoro
vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - lieky na liečbu hyperkalemia a hyperphosphatemia - velphoro je indikovaná na kontrolu hladiny fosforu v sére dospelých chronickou obličkovou chorobou (ckd) pacientov na hemodialýze (hd) alebo peritoneálnej dialýze (pd). velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate.
aktiferrin
ratiopharm gmbh, nemecko - rôzne kombinácie - 12 - antianaemica
súprava trombektomická angiojet zelantedvt
boston scientific corporation 300 boston scientific way 01752 marlborough, ma spojené štáty americké -
binocrit
sandoz gmbh - epoetín alfa - anemia; kidney failure, chronic - antianemické prípravky - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis;, treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e. kardiovaskulárny stav, existujúce anémie na začiatku chemoterapia).